康芝药业：关于公司股价异动的公告

Core Viewpoint - Kangzhi Pharmaceutical's stock price experienced an abnormal fluctuation, with a cumulative increase of over 30% in closing prices over three consecutive trading days [1] Summary by Relevant Sections - Stock Price Movement - The stock price of Kangzhi Pharmaceutical rose significantly, with a cumulative increase exceeding 30% on November 14, 17, and 18, 2025, indicating unusual trading activity [1] - Company's Response - The company conducted a self-examination and verified with its controlling shareholders, actual controllers, and all directors, supervisors, and senior management regarding the related issues [1] - Disclosure Status - As of the date of the announcement, the company confirmed that there were no significant matters that should have been disclosed but were not [1]